Position in ENTA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$212,297
-$1,362,873 QoQ
Shares Held
16,809
-83.2% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $2,946,405,239 across 415 Biotechnology names. ENTA ranks #182 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
448,371 | $346,429,369 | |
| 2 | MRNA |
Moderna, Inc.
|
4,317,219 | $219,314,725 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
415,625 | $185,593,187 | |
| 4 | BNTX |
BioNTech SE
|
1,651,789 | $146,811,006 | |
| 5 | ARGX |
Argenx SE
|
177,836 | $129,864,739 | |
| 6 | INSM |
INSMED Inc
|
604,600 | $98,864,192 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,307,176 | $97,070,889 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
280,965 | $92,962,889 |
All Filings in ENTA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $212,297 | 16,809 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,575,170 | 99,884 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $237,245 | 19,820 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $296,775 | 39,256 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $262,790 | 47,607 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $408,848 | 71,104 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $366,837 | 35,409 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $450,811 | 34,758 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $430,965 | 24,683 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $465,409 | 49,459 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $619,365 | 55,449 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,002,654 | 46,853 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $936,509 | 23,158 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,086,195 | 23,349 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,367,345 | 26,361 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $293,215 | 6,203 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $600,972 | 8,443 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $1,850,431 | 24,745 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,069,959 | 18,834 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $330,427 | 7,508 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $385,879 | 7,824 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $126,552 | 3,006 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $221,804 | 4,845 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $1,180,888 | 23,519 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $1,729,333 | 33,625 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||